Skip to content

Palonosetron for day care gynaecological procedures

Comparison of different doses of palonosetron for postoperative nausea vomiting in patients undergoing day care laparoscopic gynecological procedures- A Randomized controlled Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/09/004987
Enrollment
120
Registered
2014-09-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Palonosetron 1mcg/kg: Palonosetron 1mcg/kg given before induction of anaesthesia Intervention2: Palonosetron 1mcg/kg: Palonosetron 1mcg/kg given before induction of anaesthesia Control

Sponsors

PGIMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA physical status I or II age group of 18-60 years undergoing laparoscopic gynaecological procedures on day care basis

Exclusion criteria

Exclusion criteria: Patients allergic to 5HT3 receptor antagonist , history of gastrointestinal diseases,history of motion sickness ,history of postoperative nausea vomiting , having body mass index >30 or if the surgical procedure was converted to laparotomy

Design outcomes

Primary

MeasureTime frame
complete response during for the first 72Timepoint: complete response during for the first 72

Secondary

MeasureTime frame
Postoperative nausea vomitingTimepoint: 2,6,12,24,48,72 hrs

Countries

India

Contacts

Public ContactDivya Jain

PGIMER

jaindivya77@rediffmail.com91-9855900171

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 3, 2026